Comments
Loading...
HOOKIPA Pharma (HOOK) Forecast
NewsEarningsHOOKIPA Pharma (HOOK) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestHOOKIPA Pharma (NASDAQ:HOOK) Stock Quotes, Forecast and News Summary
HOOKIPA Pharma Stock (NASDAQ: HOOK) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy HOOKIPA Pharma (HOOK) stock?
You can purchase shares of HOOKIPA Pharma (NASDAQ:HOOK) through any online brokerage.
Who are HOOKIPA Pharma (HOOK) competitors?
Other companies in HOOKIPA Pharma’s space includes: Curis (NASDAQ:CRIS), CARISMA Therapeutics (NASDAQ:CARM), Nanoviricides (AMEX:NNVC), Bolt Biotherapeutics (NASDAQ:BOLT) and Palatin Techs (AMEX:PTN).
What is the forecast, or price target, for HOOKIPA Pharma (HOOK) stock?
HOOKIPA Pharma has a consensus price target of $5.96.
What is the current price for HOOKIPA Pharma (HOOK)?
The stock price for HOOKIPA Pharma (NASDAQ: HOOK) is $1.8472 last updated February 21, 2025 at 10:22 AM EST.
Does HOOKIPA Pharma (HOOK) pay a dividend?
There are no upcoming dividends for HOOKIPA Pharma.
When is HOOKIPA Pharma (NASDAQ:HOOK) reporting earnings?
HOOKIPA Pharma’s Q1 earnings are confirmed for Thursday, May 8, 2025.
Is HOOKIPA Pharma (HOOK) going to split?
There is no upcoming split for HOOKIPA Pharma.
What sector and industry does HOOKIPA Pharma (HOOK) operate in?
HOOKIPA Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.